Literature DB >> 3488276

Immunological studies in patients with alcoholic liver disease: evidence for the in vivo activation of helper T cells and of the monocyte-macrophage system.

F Spinozzi, R Guerciolini, R Gerli, I Gernini, F Rondoni, A Frascarelli, P Rambotti, F Grignani, S Davis.   

Abstract

Immunologic parameters were evaluated in 22 patients with alcoholic liver disease (ALD). Patients with ALD had increased levels of circulating immune complexes (CIC) and serum immunoglobulins, particularly IgA. The classical complement pathway was preferentially activated in CIC-positive patients. There was no increase in total lymphocyte or total T lymphocyte counts, but a significant rise in both the helper/inducer population (OKT4) and helper/suppressor cell ratio (T4/T8) was noted. The presence of interleukin-2 receptors and HLA-DC/DS and HLA-DR antigens suggested in vivo activation of ALD patients' T cells. The rate of differentiation of B cells to plasma cells was high in both pokeweed mitogen-stimulated and unstimulated cultures of ALD patients' B cells, whereas plasma cell generation doubled when patient T lymphocytes were added to enriched normal B cells. The above data support a role for activated helper (T4+) T cells in the immune response initiated by alcoholic hepatitis. Serum angiotensin-converting enzyme levels and lysozyme levels were increased in ALD patients, and cultured adherent mononuclear cells from ALD patients secreted more lysozyme in vitro than normal cells, suggesting the presence of an activated monocyte-macrophage system in ALD.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488276     DOI: 10.1159/000234082

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  3 in total

1.  Activated CD-8 cells and HLA DR expression in alcoholics without overt liver disease.

Authors:  R T Cook; M J Garvey; B M Booth; J A Goeken; B Stewart; M Noel
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

2.  Immunologic abnormalities in chronic fatigue syndrome.

Authors:  N G Klimas; F R Salvato; R Morgan; M A Fletcher
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  T-lymphocyte activation pathways in alcoholic liver disease.

Authors:  F Spinozzi; A Bertotto; F Rondoni; R Gerli; F Scalise; F Grignani
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.